{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"A PHASE 1, FIRST-IN-human, open-label study to evaluate the safety, tolerability, PK, and preliminary anti-tumor activity of the novel oral CDK2 DEGRADER NKT3964 in \nadults with advanced\/metastatic solid tumors","item":"https:\/\/www.regionalcancercare.org\/trials\/a-phase-1-first-in-human-open-label-study-to-evaluate-the-safety-tolerability-pk-and-preliminary-anti-tumor-activity-of-the-novel-oral-cdk2-degrader-nkt3964-in-adults-with-advanced-metastatic-so\/#breadcrumbitem"}]}